Oral Medication Shows Promise for Postpartum Depression in Phase 3 Trial
This study was funded by Sage Therapeutics, which also manufactures brexanolone.To read more on this topic, see thePsychiatric News article “Novel Medication Speeds Recovery From Postpartum Depression. ”(Image: iStock/fotostorm)For previous news alerts,click here.
Source: Psychiatr News - Category: Psychiatry Tags: antidepressant brexanolone JAMA Psychiatry oral medication postpartum depression Sage Therapeutics zuranolone Source Type: research
More News: Anxiety | Depression | Headache | Hospitals | Migraine | Postnatal Depression | Pregnancy | Psychiatry | Statistics | Study | Women